Companies/ODI Pharma AB
Follow
ODI Pharma AB
Spotlight (Sweden)
ODI Pharma is a manufacturer and supplier of medical cannabis products. The business is run through subsidiaries and partners where sales are executed through wholesale distributors and pharmacies. The products are used in the treatment of multiple sclerosis, chronic pain and in chemotherapy. Business operations are mainly located in the European market, with the head office in Stockholm.
Sector:
HEALTH CARE
>
Pharmaceuticals
Media
www.odipharma.com
Current instruments
Type
Ticker
ISIN
SHARE
ODI
SE0013409760
Spotlight Sweden (SE)
Top
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
ODI
SE0013409760
Spotlight
Sweden (SE)
Details of share in ODI Pharma AB with ticker ODI
Status
Active
Order book id
5SSJ
Amount of instruments
15 220 000
Par value
40.0000
Currency
SEK
First trading date
23 Jan 2020
Type
Price
Pre-money valuation
Time
Files
IPO
9.20 SEK
115M SEK
16 Dec - 30 Dec 2019
IPO in ODI Pharma AB
Please sign in to view the full information or
Sign up for free
People
Derek Simmross
CEO
Volker Wiederrich
Chairman of the board
Derek Simmross
Board member
Gösta Lidén
Board member
Karina Kilinski
Board member
Company Details
Sector
HEALTH CARE
Website
Address
Engelbrektsgatan 9-11
Zip code
114 32
City/district
Stockholm
Country
Sweden (SE)
Phones
Email
info@odipharma.com
Registration number
559223-1392
LEI code
8945001MNHCQFIP27M14
First trade date
23 Jan 2020
Registration date
21 Oct 2019
Short name
ODI Pharma

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date